Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9249525rdf:typepubmed:Citationlld:pubmed
pubmed-article:9249525lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C0442802lld:lifeskim
pubmed-article:9249525lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:9249525pubmed:issue1 Pt 2lld:pubmed
pubmed-article:9249525pubmed:dateCreated1997-9-3lld:pubmed
pubmed-article:9249525pubmed:abstractTextExperiments were designed to examine the effect of 17 beta-estradiol on lipopolysaccharide (LPS)-induced excessive nitric oxide production in vivo. Ovariectomized and sham-operated female rats were injected with LPS (5 mg/kg ip), and different groups of ovariectomized, LPS-injected animals were treated with either 17 beta-estradiol, dexamethasone, or aminoguanidine. Nitric oxide generation was estimated by measuring plasma nitrite levels 12 h after LPS injection. LPS treatment of the rats resulted in a four- to fivefold increase in circulating plasma nitrite level, significantly higher in the ovariectomized animals compared with the sham-operated animals. The LPS-induced plasma nitrite increase could be prevented by dexamethasone (3 mg/kg ip) injected 1 h before LPS treatment. 17 beta-Estradiol (3 micrograms/rat sc), administered 48 h before LPS treatment, significantly attenuated the LPS-induced elevation in plasma nitrite levels. This effect was comparable to that achieved by aminoguanidine (200 microM/kg), an inhibitor of inducible nitric oxide synthase, injected 1 h after LPS treatment. The present findings suggest that estrogens may be beneficial in pathological conditions associated with excessive nitric oxide generation.lld:pubmed
pubmed-article:9249525pubmed:languageenglld:pubmed
pubmed-article:9249525pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:citationSubsetIMlld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9249525pubmed:statusMEDLINElld:pubmed
pubmed-article:9249525pubmed:monthJullld:pubmed
pubmed-article:9249525pubmed:issn0002-9513lld:pubmed
pubmed-article:9249525pubmed:authorpubmed-author:TseJJlld:pubmed
pubmed-article:9249525pubmed:authorpubmed-author:RubanyiG MGMlld:pubmed
pubmed-article:9249525pubmed:authorpubmed-author:KauserKKlld:pubmed
pubmed-article:9249525pubmed:authorpubmed-author:SonnenbergDDlld:pubmed
pubmed-article:9249525pubmed:issnTypePrintlld:pubmed
pubmed-article:9249525pubmed:volume273lld:pubmed
pubmed-article:9249525pubmed:ownerNLMlld:pubmed
pubmed-article:9249525pubmed:authorsCompleteYlld:pubmed
pubmed-article:9249525pubmed:paginationH506-9lld:pubmed
pubmed-article:9249525pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:meshHeadingpubmed-meshheading:9249525-...lld:pubmed
pubmed-article:9249525pubmed:year1997lld:pubmed
pubmed-article:9249525pubmed:articleTitle17 beta-Estradiol attenuates endotoxin-induced excessive nitric oxide production in ovariectomized rats in vivo.lld:pubmed
pubmed-article:9249525pubmed:affiliationCardiovascular Department, Berlex Biosciences, Richmond, California 94806-0099, USA.lld:pubmed
pubmed-article:9249525pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9249525lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9249525lld:pubmed